Investor RelationsIR Library
Fiscal Year 2024 (From April 1, 2024 to March 31, 2025)
Year End [Announced on May 12, 2025]
- Consolidated Financial Results for the Year Ended March 31, 2025 [Japanese GAAP] (266KB)
- Notice of differential between performance forecast and results, and Concerning Dividends of Surplus (126KB)
- Notice of Regarding the Increase of Non-operating Expenses (Foreign Exchange Loss) (140KB)
- IR Materials (1,179KB)
- Medium-term management plan (3,313KB)
- Financial Results Presentation Material Domestic Division Business Report（1,409KB）
- Financial Results Presentation Material International Business Strategy Promotion of Global Management（2,818KB）
- Financial Results Presentation Material Pharmaceutical Business Strategy（2,040KB）
- Financial Results Presentation Material Business Strategy of the Pharma Packaging Business（1,014KB）
- Financial Results Presentation Material New medium-term management plan（1,561KB）
The Third Quarter [Announced on February 7, 2025]
- IR Materials (993KB)
The Second Quarter [Announced on November 8, 2024]
- IR Materials (1,379KB)
The First Quarter [Announced on August 8, 2024]
- IR Materials (926KB)